PharmaSGP Holding SE (PSG) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.115x

Based on the latest financial reports, PharmaSGP Holding SE (PSG) has a cash flow conversion efficiency ratio of 0.115x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.22 Million ≈ $4.94 Million USD) by net assets (€36.67 Million ≈ $42.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PharmaSGP Holding SE (PSG) market capitalisation for the company's overall valuation and market capitalisation.

PharmaSGP Holding SE - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PharmaSGP Holding SE's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PharmaSGP Holding SE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmaSGP Holding SE ranked by their cash flow conversion efficiency. Explore PSG cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Zilltek Technology Corp TWO:6679	0.028x
Suzhou Fushilai Pharmaceutical Co. Ltd. SHE:301258	N/A
Nanjing Chervon Auto Precision Technology Co Ltd SHG:603982	0.065x
Baader Bank Aktiengesellschaft F:BWB	N/A
Top Bright Holding Co Ltd TW:8499	0.024x
Bell Financial Group Ltd AU:BFG	0.188x
Everyday Network SHE:300295	0.074x
Polisan Holding AS IS:POLHO	0.019x

Annual Cash Flow Conversion Efficiency for PharmaSGP Holding SE (2014–2024)

The table below shows the annual cash flow conversion efficiency of PharmaSGP Holding SE from 2014 to 2024. View PharmaSGP Holding SE share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€31.96 Million ≈ $37.37 Million	€24.88 Million ≈ $29.08 Million	0.778x	+16.15%
2023-12-31	€39.75 Million ≈ $46.48 Million	€26.64 Million ≈ $31.14 Million	0.670x	-15.68%
2022-12-31	€31.10 Million ≈ $36.36 Million	€24.71 Million ≈ $28.89 Million	0.795x	+44.12%
2021-12-31	€22.20 Million ≈ $25.95 Million	€12.24 Million ≈ $14.31 Million	0.551x	-58.95%
2020-12-31	€11.51 Million ≈ $13.45 Million	€15.46 Million ≈ $18.07 Million	1.343x	+628.25%
2019-12-31	€95.58 Million ≈ $111.74 Million	€17.63 Million ≈ $20.61 Million	0.184x	-20.63%
2017-12-31	€61.32 Million ≈ $71.68 Million	€14.25 Million ≈ $16.66 Million	0.232x	+276.99%
2016-12-31	€57.53 Million ≈ $67.26 Million	€3.55 Million ≈ $4.15 Million	0.062x	-68.67%
2015-12-31	€53.79 Million ≈ $62.88 Million	€10.59 Million ≈ $12.38 Million	0.197x	+75.71%
2014-12-31	€48.27 Million ≈ $56.43 Million	€5.41 Million ≈ $6.32 Million	0.112x	--

About PharmaSGP Holding SE

F:PSG Germany

Market Cap

$387.63 Million

€331.56 Million EUR

Market Cap Rank

#14454 Global

#1448 in Germany

Share Price

€28.80

Change (1 day)

+0.00%

52-Week Range

€28.80 - €28.80

All Time High

€32.32